Loading company…
Westlake Therapeutics (Hangzhou) Co., Ltd., founded in 2020 in Hangzhou, China, develops red blood cell-based cell therapies.
Established in 2020 and based in Hangzhou, China, Westlake Therapeutics (Hangzhou) Co., Ltd. researches and develops red blood cell-based cellular medicines. Its pipeline covers lung cancer, cervical cancer, gout, and sepsis, and its red blood cell engineering platform produces engineered red blood cells from human peripheral blood stem cells or adult red blood cells. In June 2026 it raised over CNY 100 million in venture funding co-led by Taiping Guofa and Real Power Capital, with Efung Capital, Huafang Capital, HSG, and other investors participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in